Search

Your search keyword '"Sakanoue I"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Sakanoue I" Remove constraint Author: "Sakanoue I"
97 results on '"Sakanoue I"'

Search Results

3. Expert consensus on perioperative treatment for non-small cell lung cancer

19. Single Center Experience of Clinical Ex Vivo Lung Perfusion

26. Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes.

27. Impact of Ex Vivo Lung Perfusion on a Lung Transplant Program: A Single Center Experience.

28. Back-Table Evaluation Prior to Ex-Vivo Lung Perfusion: An Approach for Improving Utilization Rates.

29. Influence of HLA mismatch between donors and recipients on postoperative outcomes in cadaveric lung transplantation.

30. Real-time lung weight measurement during clinical ex vivo lung perfusion.

31. Adult living-donor lobar lung transplant using a small-for-size graft.

32. Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma.

33. Pulmonary metastasectomy after immune checkpoint inhibitors in malignant melanoma.

34. Pneumocephalus resulting from traumatic pneumothorax and brachial plexus avulsion.

35. Intermittent Ex Vivo Lung Perfusion in a Porcine Model for Prolonged Lung Preservation.

36. Left ventricular assist device mode: Co-pulse left ventricular unloading in a working mode of ex vivo heart perfusion.

37. Real-time Lung Weight Measurement During Cellular Ex Vivo Lung Perfusion: An Early Predictor of Transplant Suitability.

38. Prone ex vivo lung perfusion protects human lungs from reperfusion injury.

39. Expert consensus on perioperative treatment for non-small cell lung cancer.

40. Clinical significance of donor lung weight at procurement and during ex vivo lung perfusion.

41. The Effect of Blood Transfusion in Lung Donors on Recipient Survival.

42. Successful Lung Transplantation After Acellular Ex Vivo Lung Perfusion With Prone Positioning.

43. Lung Transplant for Patient With Idiopathic Pneumonia Syndrome.

44. Cellular Ex Vivo Lung Perfusion Beyond 1 Hour May Improve Marginal Donor Lung Assessment.

46. Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer.

47. Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263.

48. Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.

49. Reduced Tumour Proportion Scores for Programmed Cell Death Ligand 1 in Stored Paraffin Tissue Sections.

50. Sleeve lobectomy for lung adenocarcinoma treated with neoadjuvant afatinib.

Catalog

Books, media, physical & digital resources